Li DJ, et al. (2021) NAD(+)-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin. Theranostics 11(9):4381-4402
Paste the following link
Lists
This AllelePublication isn't in any lists. Upload a list.